No profile data available.
Clearmind Medicine Inc. (CMND) is a healthcare company in the poison treatment pharmaceuticals industry, based in Vancouver, Canada.
It reported revenue of $0 for fiscal year 2025, and net income of -$3.86 million. In Q1 2026 (the quarter ended January 31, 2026) revenue was $0. Its market capitalization was $3.34 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended October 31, 2025; market data as of October 9, 2026.
, a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems.
Clearmind Medicine reported $0 in revenue for fiscal year 2025. In Q1 2026 revenue was $0.
$3.34 million as of October 9, 2026.
Listed companies of a similar size in the same industry (poison treatment pharmaceuticals) include Anebulo Pharmaceuticals, Inc. (ANEB), Adial Pharmaceuticals, Inc. (ADIL), Addex Therapeutics Ltd (ADXN).